Comparing two methods for preventing pancreatic fistula after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of reinforced pancreaticojejunostomy using a tissue adhesive (glubran 2) compared to the standard technique without the adhesive in patients undergoing pancreaticoduodenectomy for cancer. The research focuses on reducing the incidence of pancreatic fistula, a serious complication following this type of surgery. By analyzing long-term clinical outcomes, the study seeks to determine the best method for preventing this complication. The use of tissue adhesives is explored for their potential to enhance surgical techniques and improve patient recovery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All the patients undergoing pancreaticoduodenectomy for cancer
* Patients able to give their informed consent

Exclusion Criteria:

* Unfit patients for surgery due to severe medical illness.
* Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
* Presence of distant metastasis .
* Patients refused to participate in the study.

Where it's running

• Liver and GIT hospital / Minia university
  Minya, Egypt Recruiting

Study contacts

• Principal investigator: Saleh K Saleh, MD — Minia University
• Study coordinator: Saleh K Saleh, MD
• Email: salehkhairy@mu.edu.eg
• Phone: 01201765401

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting pancreatic fistula after pancreaticoduodenectomy

  This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.

  Recruiting Minia University · Minya · NCT07022015

• Using Lipidica software to screen for pancreatic cancer in high-risk patients

  This study is testing a new software called Lipidica to see if it can help find pancreatic cancer earlier in people who are at high risk because of their genetics or family history.

  Recruiting at 15 sites Lipidica, a.s. · Prague, Czechia and 15 other locations · NCT06549725

• Analyzing factors affecting pancreatic tumors and cysts

  This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.

  Recruiting Umeå University · Umeå · NCT05155878

• Research on early detection of pancreatic cancer

  This study is trying to find better ways to detect pancreatic cancer early by looking at people who are at high risk because of their family history or genetics.

  Recruiting at 57 sites Arbor Research Collaborative for Health · Phoenix, Arizona and 61 other locations · NCT04970056

• Treatment for metastatic cancer with BRCA or PALB2 mutations using chemotherapy and stem cells

  This study is testing a new treatment combining chemotherapy and stem cells for people with metastatic pancreatic or breast cancer who have BRCA or PALB2 mutations to see if it is safe and effective.

  Recruiting Phase 1 General Oncology, Inc. · Boston, Massachusetts and 1 other locations · NCT04150042

• Using contrast-enhanced ultrasound to check for local pancreatic cancer recurrence after surgery

  This pilot test uses contrast-enhanced ultrasound to see if it can help detect return of pancreatic cancer after surgery in patients being watched with CT scans.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07910383

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.